Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0001193125-26-452004

Chief Scientific Officer sold 4,000 shares at $12.36 ($49,440)

  • Chief Scientific Officer acquired 3,805 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Michaelson Jennifer Chief Scientific Officer 2026-11-05 Option exercise 10b5-1 +3,805 $4.30 $16,362 162,649 D
Michaelson Jennifer Chief Scientific Officer 2026-11-05 Sale 10b5-1 −4,000 $12.36 $49,440 158,649 D
Derivatives
Michaelson Jennifer Chief Scientific Officer 2026-11-05 Option exercise · Stock Option (Right to Buy) 10b5-1 −3,805 75,182 D
Open-market sales · 4,000 sh · avg $12.36 · $49,440
Loading xslF345X06/ownership.xml…